Isabelle Tennevet is an expert in Oncology at Centre Henri Becquerel (France). Isabelle Tennevet has authored 40 publications, the most recent in 2025, and is an investigator in 10 clinical trials. SLR score: 103 (community average: 125). How the SLR is computed.

LeadR Profile

Isabelle Tennevet Centre Henri Becquerel France
103 ScienceLeadR Reputation 103
Network Map

Oncology

Subspecialties: Neurology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2012 - 2025

Source: PubMed

Centre Henri Becquerel

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 40

Citations

Citations: 3 505 1st author: 0 Last author: 0 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Letrozole to prevent breast cancer in postmenopausal women with BRCA1/2 mutations (LIBER study).
PMID 41240533 — quality of life, breast neoplasms, incidence, neoplasms, letrozole, breast, artificial intelligence, genes, brca1, mutation
Eur J Cancer20251
The clinical impact of EGFR alterations in elderly glioblastoma patients: results from a real-life cohort.
PMID 39549128 — aged, glioblastoma, nervous system neoplasms
J Neurooncol20240
Metabolic remodeling in glioblastoma: a longitudinal multi-omics study.
PMID 39394177 — neoplasms, multiple chronic conditions, biopsy, metabolomics, proteomics, glioblastoma, plasma
Acta Neuropathol Commun20245
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY.
PMID 38112922 — therapeutics, breast neoplasms, safety, disease-free survival, cyclin-dependent kinases, cyclins, cyclin-dependent kinase 4, progression-free survival, chemotherapy
Breast Cancer Res Treat20239
Prognostic value of circulating short-length DNA fragments in unresected glioblastoma patients.
PMID 38340682 — adrenal cortex hormones, glioblastoma, dna, neoplasms, chemoradiotherapy
Transl Oncol20241

Clinical Studies 10

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

Phase 2 5
Phase 3 4
N/A 1

By status:

Completed 8
Active not recruiting 1
Recruiting 1

By type:

Interventional 10

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 0
multicentric5to9 0
multicentricup10 6

Main Topics

Cohort/Consortium Investigators 3

LeadR Networks

Main global connection map